InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001199719-21-000086 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-09-17 2021-09-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec M - OptEx $107.10 +4,238 21.2K +25% +$453.9K
DM 2021-09-17 2021-09-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec S - Sale+OE $333.00 -4,238 19.6K -18% -$1.41M
DM 2021-09-17 2021-09-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec M - OptEx $0.00 -4,238 6,614 -39% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-15 M A 1,343 $90.51 20,969 D — —
2 Common Common Stock 2021-09-15 S D 1,323 $333.00 19,626 D — —
3 Common Common Stock 2021-09-15 M A 1,323 $89.76 20,949 D — —
4 Common Common Stock 2021-09-15 S D 1,572 $333.00 19,626 D — —
5 Common Common Stock 2021-09-15 M A 1,572 $135.88 21,198 D — —
6 Common Common Stock 2021-09-15 S D 1,343 $333.00 19,626 D — —
7 Derivative Non-Qualified Stock Option (right to buy) 2021-09-15 M D 1,572 $0.00 14,148 D $135.88 · 2020-12-12 to 2026-12-12 1,572 Common Stock (F1) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
8 Derivative Non-Qualified Stock Option (right to buy) 2021-09-15 M D 1,343 $0.00 1,343 D $90.51 · 2018-12-08 to 2024-12-08 1,343 Common Stock (F1) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
9 Derivative Non-Qualified Stock Option (right to buy) 2021-09-15 M D 1,323 $0.00 6,614 D $89.76 · 2019-12-12 to 2025-12-12 1,323 Common Stock (F1) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.